Mr. Christopher Cherry reports

MEDBRIGHT AI APPOINTMENTS CHRISTOPHER CHERRY AS INTERIM CEO

Medbright AI Investments Inc. has appointed Christopher Cherry as interim chief executive officer, effective Jan. 13, 2025. Mr. Cherry currently sits as a director of the company and will seamlessly assume the role.

The company expresses appreciation to Chris Heath for his contribution as CEO and wishes him the best in his future endeavours.

About Medbright AI Investments Inc.

Medbright AI is a capital allocator focused on investing in diversified industries, including technology, health care and artificial intelligence. These include both public and private companies. Medbright has a focus on near-term and midterm high-quality opportunities with strong return potentials while maintaining its commitment to governance.